Carisma Therapeutics, Inc.
CARMOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$4185
P/E Ratio—
52W High$1.27
52W Low$0.0001
Carisma Therapeutics, Inc.（CARM）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CARM · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $19.63M | $14.92M | $9.83M | $26.54M | $11.24M |
| Cost of Revenue | $59.67M | $74.13M | $0.00M | $0.09M | $0.00M |
| Gross Profit | ($40.04M) | ($59.21M) | $9.83M | $26.46M | $11.24M |
| Gross Margin %(computed) | -203.96% | -396.85% | 100.00% | 99.68% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $59.67M | $74.13M | $56.62M | $25.23M | $23.29M |
| G&A Expenses | $20.14M | $29.52M | $9.38M | $0.00M | $5.09M |
| Total Operating Expenses | $22.14M | $29.52M | $66.00M | $54.62M | $28.38M |
| Operating Income | ($62.18M) | ($88.73M) | ($56.16M) | ($28.16M) | ($28.38M) |
| Operating Margin %(computed) | -316.72% | -594.75% | -571.10% | -106.09% | -252.56% |
| Interest Income | $1.70M | $1.94M | $0.00M | $0.01M | $0.03M |
| Interest Expense | $0.00M | $0.00M | $3.15M | $0.00M | $0.00M |
| Income Before Tax | ($60.48M) | ($86.88M) | ($61.23M) | ($8.61M) | ($28.35M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | ($8.27M) | $0.00M |
| Net Income | ($60.48M) | ($86.88M) | ($61.23M) | ($0.34M) | ($28.35M) |
| Net Margin %(computed) | -308.05% | -582.34% | -622.60% | -1.27% | -252.31% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.46 | $-2.59 | $-1.52 | $-0.04 | $-3.81 |
| Wtd Avg Shares | 41.46M | 33.52M | 40.26M | 9.12M | 5.91M |
| EBITDA | ($56.83M) | ($85.89M) | ($56.19M) | ($8.52M) | ($27.93M) |
| EBITDA Margin %(computed) | -289.45% | -575.74% | -571.36% | -32.11% | -248.58% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Carisma Therapeutics, Inc.
关于Carisma Therapeutics, Inc.（CARM）损益表
Carisma Therapeutics, Inc.（CARM）损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年，CARM实现营收$0.02B，毛利润($0.04B)（毛利率-203.96%），净利润($0.06B)（净利率-308.05%）。
常见问题
CARM · 4 问Carisma Therapeutics, Inc.（CARM）2024财年营收为$0.02B，同比up31.6%。
CARM revenueCARM salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09